课题基金 / 基金详情

Knock-down mouse, a novel gene engineering mouse for use as a disease model

Knock-down mouse, a novel gene engineering mouse for use as a disease model
击倒小鼠,一种用作疾病模型的新型基因工程小鼠
批准号:
11480251
负责人:
OHNISHI Yasuyuki
金额:
$9.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

OHNISHI Yasuyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this research, we attempt to create a novel gene engineering mouse which contains the target gene expression-switch such as tetracycline regulated gene expression system (Tet-OFF and Tet-ON) and a gene for ribizyme driven by the switch system. First, we constructed an anti-insulin ribozyme, and examined in vitro cleaving assay using synthesized insulin RNA and the ribozyme. The ribozyme showed in vitro cleavage activity to the RNA.The ribozyme also showed anti-insulin activity in M6 insulinoma cell transfectant system. Another ribozymes were created for VEGF (vascular endotherial growth factor) and activated K-ras gene RNA, and they showed cleaving activity in cell transformant and in vitro cleavage assay system.Also, tumor cells transfected by the anti-VEGF or anti-K-ras ribozyme showed reduced tumorigenic activity in nude mouse. Transgenic mice for rusiferase gene driven by the Tet-OFF and Tet-ON system were created. The mice were under exanimation.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Oshika,Y: "Ribozyme approach to downregulate vascular endothelial growth factor (VEGF) 189 expression in non-small cell lung cancer (NSCLC)"Eur.J.Cancer. 36. 2390-2396 (2000)
Oshika,Y:“核酶方法下调非小细胞肺癌 (NSCLC) 中血管内皮生长因子 (VEGF) 189 的表达”Eur.J.Cancer。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    Establishment of human tumor xenotransplantation models as a pre-clinical assisting tool for translational research
    • 批准号:
      13480283
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.26万
    • 财政年份:
      2001
    • 负责人:
      OHNISHI Yasuyuki
    • 依托单位:
    Studies on in vivo evaluation system of treatment for cancer prevention and progression using cancer prone gene-engineered mice
    • 批准号:
      12558097
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.45万
    • 财政年份:
      2000
    • 负责人:
      OHNISHI Yasuyuki
    • 依托单位:
    Improvement of human tumor xenograft-mouse model as a preclinical evaluation system of new drugs discovered and developed by the novel strategy against cancer
    • 批准号:
      08458278
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $1.73万
    • 财政年份:
      1996
    • 负责人:
      OHNISHI Yasuyuki
    • 依托单位:
    A new approach for prediction of clinical efficacy of anticancer drugs based on toxicokinetic and pharmacokinetic analysis
    • 批准号:
      07558117
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $5.31万
    • 财政年份:
      1995
    • 负责人:
      OHNISHI Yasuyuki
    • 依托单位:
    国内基金
    海外基金
    增强子在小鼠早期胚胎细胞命运决定中的功能和调控机制研究
    • 批准号:
      82371668
    • 项目类别:
      面上项目
    • 资助金额:
      52.00万元
    • 批准年份:
      2023
    • 负责人:
      乔云波
    • 依托单位:
    睾丸特异性新基因TSC29的表达调控机制及其功能研究
    • 批准号:
      81170613
    • 项目类别:
      面上项目
    • 资助金额:
      54.0万元
    • 批准年份:
      2011
    • 负责人:
      唐爱发
    • 依托单位:
    mir-125b在1型糖尿病自身免疫性胰岛炎中的作用及机制研究
    • 批准号:
      30901627
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2009
    • 负责人:
      韩蓓
    • 依托单位:
    转录调控中起作用的细胞周期激酶的鉴定及其作用机制研究
    • 批准号:
      30970625
    • 项目类别:
      面上项目
    • 资助金额:
      32.0万元
    • 批准年份:
      2009
    • 负责人:
      李沁桐
    • 依托单位: